India Plans To Revive Network Of Deep Discount Drug Stores
This article was originally published in PharmAsia News
Executive Summary
As price controls are applied on hundreds of drugs, the Indian government is revamping its own plans to provide cut-price unbranded generics. The move will make drugs available at one-fourth of the prevailing market rates.
You may also be interested in...
India Seeks Partners To Set Up Generic Drug Store Chain In Every District
NEW DELHI - India's government is seeking applications from pharmaceutical companies, non-governmental organizations and other groups as partners for a push to open a chain of low-cost generic drug stores
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.
Lee Takes India Compulsory License Fight To Saxagliptin
In a bold move, little known Indian drug firm Lee Pharma has applied for a compulsory license for saxagliptin in India, contending that AstraZeneca sells the diabetes drug at an exorbitant local price and that it is not being made sufficiently available. Lee also says that the originator has not responded to calls to collaborate.